Atara Biotherapeutics (ATRA)
(Delayed Data from NSDQ)
$8.03 USD
+0.25 (3.21%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $8.04 +0.01 (0.12%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth F Momentum D VGM
Earnings News For ATRA
-
Atara Biotherapeutics (ATRA) Reports Q2 Loss, Misses Revenue Estimates
-
Atara Biotherapeutics: Q2 Earnings Snapshot
-
Atara Biotherapeutics: Q1 Earnings Snapshot
-
Atara Biotherapeutics (ATRA) Reports Q1 Loss, Tops Revenue Estimates
-
Atara Biotherapeutics (ATRA) Reports Q4 Loss, Tops Revenue Estimates
-
Atara Biotherapeutics: Q4 Earnings Snapshot
-
Atara Biotherapeutics: Q3 Earnings Snapshot
-
Atara Biotherapeutics (ATRA) Reports Q2 Loss, Lags Revenue Estimates
-
Atara Biotherapeutics: Q2 Earnings Snapshot
-
Atara Biotherapeutics (ATRA) Reports Q1 Loss, Lags Revenue Estimates
-
Atara Biotherapeutics: Q1 Earnings Snapshot
-
Atara Biotherapeutics: Q4 Earnings Snapshot
-
Atara Biotherapeutics: Q4 Earnings Snapshot
-
Atara Biotherapeutics (ATRA) Reports Q4 Loss, Misses Revenue Estimates
-
Atara Biotherapeutics (ATRA) Reports Q3 Loss, Tops Revenue Estimates
-
Atara Biotherapeutics: Q3 Earnings Snapshot
-
Atara Biotherapeutics (ATRA) Reports Q2 Loss, Tops Revenue Estimates
-
Atara Biotherapeutics: Q2 Earnings Snapshot
-
Atara Biotherapeutics (ATRA) Reports Q1 Loss, Tops Revenue Estimates
-
Analysts Estimate Atara Biotherapeutics (ATRA) to Report a Decline in Earnings: What to Look Out for
-
Atara Biotherapeutics (ATRA) Reports Q4 Loss, Lags Revenue Estimates
-
Atara Biotherapeutics (ATRA) Reports Q3 Loss, Tops Revenue Estimates
-
Atara Biotherapeutics (ATRA) Reports Q2 Loss, Misses Revenue Estimates
-
Atara Biotherapeutics (ATRA) Reports Q1 Loss, Lags Revenue Estimates